Autoimmune Lymphoproliferative Syndrome - 8 Studies Found

Withdrawn : Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
:
  • Autoimmune Lymphoproliferative Syndrome
  • Lymphoma

: 2012-08-23
Recruiting : Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
: Autoimmune Lymphproliferative Syndrome
: 1999-11-03
Completed : Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
:
  • ALPS
  • Hypersplenism
  • Lymphadenopathy

: 2008-01-15
:
  • Drug: Valproic Acid Oral admin
Completed : Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
:
  • Autoimmune Disease
  • Lymphoproliferative Disorder

: 2001-03-28
: Drug: Fansidar (pyrimethamine and sulfadoxine)
Completed : Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
:
  • Autoimmune Disease
  • Lymphatic Disease
  • Lymphoproliferative D
    : 2003-07-21
    : Drug: Pyrimethamine
Completed : Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
:
  • Lymphoproliferative Disorders
  • Lymphoma

: 2003-09-09
Enrolling by invitation : Comparative Autoantibody and Immunologic Cell Marker Study
:
  • Autoimmune Diseases
  • Lupus Erythematosus, Systemic
  • Communic
    : 2015-04-17
Recruiting : Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT
:
  • Primary Immunodeficiency Syndromes
  • Congenital Bone Marrow Failure Syndromes
  • Drug: Hydroxyurea Hydroxyurea